In all, 25 of 41 patients(60.9%) had high-level TAL1 gene expression, 30%of the 43 T-ALL patients had LMO2 overexpression, and10 patients (25.6%) had a high level of LYL1 gene expression,as compared to the controls. This evidence concerns the gene LMO2 and acute lymphoblastic leukemia.